PUBLIC COMPANY
saveHemab ApS
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- —A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
- phase2A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency
- phase2A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia
- phase2A Study Assessing HMB-002 in Participants With Von Willebrand Disease
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that